Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.6206
-0.0346 (-5.28%)
Nov 13, 2026, 3:08 PM EST - Market open
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 29 employees as of December 31, 2025. The number of employees increased by 1 or 3.57% compared to the previous year. That makes Calidi Biotherapeutics the 37,228th largest employer in the world and 5,184th in the United States.
Employees
29
Change (1Y)
1
Growth (1Y)
3.57%
Revenue / Employee
n/a
Profits / Employee
-$808,793
Market Cap
2.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 1 | 3.57% |
| Dec 31, 2024 | 28 | -13 | -31.71% |
| Dec 31, 2023 | 41 | 3 | 7.89% |
| Dec 31, 2022 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Aptevo Therapeutics | 33 |
| Curis | 24 |
| VivoSim Labs | 15 |
| BioRestorative Therapies | 14 |
| Revelation Biosciences | 9 |
| Dermata Therapeutics | 9 |
| Ernexa Therapeutics | 7 |
CLDI News
- 17 days ago - Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories - GlobeNewsWire
- 25 days ago - Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026 - GlobeNewsWire
- 6 weeks ago - Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency - GlobeNewsWire
- 1 month ago - Calidi prices 1.025M shares at $1.17 in registered direct offering - TheFly
- 1 month ago - Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering - GlobeNewsWire
- 2 months ago - Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference - GlobeNewsWire